The Washington Times
  • Subscribe
  • Customer Services
  • RSS
  • Mobile Headlines
  • e-edition
  • E-MAIL ALERTS
  • REGISTER
  • LOG IN
  • E-MAIL ALERTS
  • WELCOME
  • Your Profile
  • Log Out

  • Front Page Image
  • Classifieds
  • Autos
  • Real Estate
  • Jobs
  • Special Sections
  • Times News Services
  • Home
  • News
  • Opinion
  • Sports
    • NFL
    • NBA/WNBA
    • MLB
    • NHL
    • Tennis
    • Golf
    • Motorsports
    • Soccer
    • NCAA
    • Olympics
    • Outdoors
    • Алекс Овечкин
  • Culture
    • Home & Living
    • Family & Kids
    • Fashion
    • Food
    • Travel
    • Health
    • Washington Visitors
    • Books
    • Military History
    • Life
    • Auto
    • TV Listings
    • Movie Listings
    • Death Notices
    • Entertainment
  • Themes
  • Communities
    • Donne Travels
    • Lives Common
    • National Pastime
    • Politics 101
    • Stories of Faith
    • Civil War
    • Middle - America
    • Chicago Blue State
    • Zadzooks
  • Marketplace
    • Autos
    • Jobs
    • Real Estate
    • Classifieds
    • Shopping
    • Dining Out
    • Education
    • TWT Store
  • Videos
    • Two Guys
    • Birnbaum on Washington
    • Liz Glover
    • Amanda Carpenter
    • Morning Briefing
    • Documentaries
  • Podcasts
    • About Headlines
    • Inside the Beltway
    • Inside the Story
Home > News > Latest Headlines

Report: VA failed to safeguard veterans

Handling of drug trials an 'unacceptable' failure

By Audrey Hudson (Contact)

Originally published 07:13 p.m., September 19, 2008, updated 10:29 p.m., September 19, 2008

  • Bookmark and Share
  • Article
  • Comments ()
  • Print
  • [-][+] Font Size
  • E-Mail Alerts
  • Tell a Friend
  • Got a Question?
  • You Report
  • Click-2-Listen

The Veterans Affairs Department is responsible for numerous "unacceptable failures" in ensuring safeguards for soldiers with post-traumatic stress disorder who were enrolled in a medical experiment to help them stop smoking, an internal review found Friday.

Despite the stinging report, the agency has decided to proceed with the experiment, including allowing participants to take a drug that carries risks of suicide and other psychotic behavior, officials said.

The investigation, prompted by a series of stories earlier this summer in The Washington Times as part of a joint investigation with ABC News, said that the smoking cessation study "did not adequately fulfill VA's singular responsibility to maximize safeguards for veterans who volunteer to participate in research."

The review by the VA's Office of Research Oversight (ORO) also found "unacceptable failures to maximize safeguards for the veterans who had volunteered to participate" in the study, including the lack of a system in place to alert researchers and participants when drug safety warnings are issued.

Researchers responsible for the smoking cessation study first failed to notify internal review boards that oversaw the experiment at 10 locations when the Food and Drug Administration (FDA) first publicized concerns in November that the drug varenicline, commercially known as Chantix, may induce suicidal thoughts or actual suicides.

When a second warning was issued in February it took anywhere from 16 to 134 days to alert veterans, and the review expressed doubts as to whether all veterans in the study received the warnings.

Despite a multitude of discrepancies and failures identified by the review, the study made no recommendation either in favor of terminating or of continuing the study, which involves more than 900 veterans.

VA spokeswoman Alison Aikele told The Times on Friday that the experiment will continue, and that Chantix, prescribed to 240 veterans in the study by their own doctors, will continue to be made available to the participants.

"It is an FDA-approved medication, and guidelines have been distributed to providers and information to patients," Miss Aikele said.

The smoking cessation study came under fire in June after a Washington Times/ABC News joint investigation reported that the VA had taken at least three months before it began to alert the veterans taking Chantix about the possible new side effects.

The notice came nearly one month late for Iraqi war veteran James Elliott, who suffered a mental breakdown while taking the drug. In what he later described as an attempt at "suicide by cop," Mr. Elliott was shocked with a Tazer during a stand-off with police in Silver Spring.

The report urged VA officials to conduct an investigation to "hold appropriate individuals accountable for any research protection failures in [the study], specifically including responsibility for factors contributing to undue delays in notifying participants about the risks associated with varenicline."

Rep. Bob Filner, California Democrat and chairman of the House Veterans Affairs Committee, held a July 9 hearing in response to the Times/ABC News investigation where Dr. Tom Puglisi, chief officer of the ORO and author of the review, said he feared that similar notification problems exist throughout the agency's human-subject testing programs, particularly those that target veterans with PTSD.

Dr. Puglisi's testimony then said he was "very concerned" about the study, but he did not explicitly back either canceling or continuing it. Mr. Filner and other lawmakers have demanded that the VA end the study.

The review recommended that the VA establish a reliable system to notify the researchers and study participants about new or emerging medication safety information, and the VA says it has developed an action plan to implement this and all the recommendations contained in the report.

Bookmark and Share

Comments

Read Comments

Post your comment:

Please login or register to post a comment

Do you have another point of view, photos, audio, video or more information about a story?

  • Iraq war veteran James Elliott smokes a cigarette outside of the Veterans Affairs Medical Center in Washington D.C., Thursday April 10, 2008. James was taking the prescription drug Chantix to help people stop smoking. The drug has been linked to psychotic and suicidal behavior, and deaths. (Rod Lamkey Jr/The Washington Times)

Click the photo to enlarge.

Advertisement

Top Stories

Most Read

  1. Inside the Ring
  2. EDITORIAL: Passing unread laws
  3. Senate delays climate bill until September
  4. EDITORIAL: Sotomayor's secret files
  5. YON: Girl with no future

Most Shared

  1. EDITORIAL: Passing unread laws
  2. HOLMES: Deja vu on dictators, double standards
  3. EDITORIAL: Return of the Black Panther
  4. Bloated deficits endanger dollar's global status
  5. Israeli know-how
  6. EDITORIAL: The fate of FedEx
  7. EDITORIAL: Dancing with the bear
  8. YON: Girl with no future
  9. EDITORIAL: Rewriting economic history
  10. LETTER TO EDITOR: Coming to grips with Palestinian guilty trips

Most Commented

  1. Jeb Bush, GOP: Time to leave Reagan behind
  2. WH communications director leaving
  3. Freddie Mac acting CFO found dead
  4. Kerry aims to rescue newspapers
  5. Fidel Castro: Obama 'misinterpreted' words
  6. President Obama said those who approved harsh interrogation techniques for suspected terrorists may be subjected to criminal charges. Do you agree?
  7. President Obama said those who approved harsh interrogation techniques for suspected terrorists may be subjected to criminal charges. Do you agree?
  8. Gibbs: Pay no attention to what Rahm said
  9. Politics' Talking Heads Highlight Speaker Series
  10. Fleecing Mike Ditka

Related Stories

Obama lashed by own words in GOP ad

GOP hits Obama using his own words

Tuning In to TV

ABC employees donated heavily to Obama

Networking with Obama

Summertime's crazy new TV

EXCLUSIVE: Perino slams ABC News-WH deal

Inside Politics

GOP fears slant in ABC news special

Shooting suspect's son is 'sorry'

Poll

Do you think the G-8 is still effective in today's times?

Market Data

Advertising Links
TWT Store
  • e-edition
  • Print Edition
  • Weekly Washington Times
TWT Affiliates
  • Middle East Times
  • Golf
  • UPI
  • Arbor Ballroom
  • Washington Times Global
  • About TWT
  • Press Room
  • F.A.Q.
  • Work for TWT
  • Advertise
  • Sponsors
  • Contact Us
  • Privacy Policy
  • Site Map

All site contents © Copyright 2009 The Washington Times, LLC.